Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > It’s hard to see tlt
View:
Post by Corvette65 on Jun 08, 2024 7:28pm

It’s hard to see tlt

Struggle at these price's.   I believe the system is broke. The exchange's and the shorting work against small companies with great ideas to raise money to create jobs and eventually help us beat a horrible disease. TLT should be much higher if it was for the rules the exchange have in place after the news this past week. I have talked Roger several times in the past about the exchange we are on. I been here about 14 years and still have a lot of hope for a great science to prevail despite every thing that keeps holding us down.
Comment by Alamir1111 on Jun 08, 2024 8:31pm
Looks like shorts let down a bit Historical Short Volume Data for TLTFF Date Close High Low Volume Short Volume % of Vol Shorted Jun 06 NA NA NA 130,666 62,916 48.15 Jun 05 NA NA NA 57,792 50,682 87.70  ...more  
Comment by CancerSlayer on Jun 08, 2024 9:15pm
It's really a shame that smaller companies with incredible promise (for society) has to jump through so many unnecessary hoops.  The recent positive news on the antiviral & cancer fronts can perhaps provide better access to public monies on the Canadian side.  I don't see how a public official(s) could discount the potentially life-changing human impact (on a global scale ...more  
Comment by Johnandrose22 on Jun 08, 2024 9:32pm
I, too, have come to believe that initial financial support for the company will not come from the private/corporate sector but from government/societal interests who recognize how TLD 1433 can protect all of us. The corporate sector will then follow suit....and the staggering value of this company and its assets will be unlocked. It will be a pleasure to shake your hand at our gathering. Sir ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250